Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
54
VMD Quote, Financials, Valuation and Earnings
Last price:
$6.75
Seasonality move
:
6.07%
Day range:
$6.57 - $6.84
52-week range:
$6.14 - $9.81
Dividend yield:
0%
P/E ratio:
22.50x
P/S ratio:
1.19x
P/B ratio:
1.98x
Volume:
139.1K
Avg. volume:
178.3K
1-year change:
-5.06%
Market cap:
$266.8M
Revenue:
$224.3M
EPS (TTM):
$0.30
Earnings Data
Next earnings date for VMD
Aug 08
2025
Most recent earnings per share
$0.06
Beat by $0.06
(May 8/2025)
Consensus Estimate
--
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VMD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/08/2025 | Q2 | $63.3M | -- | -- | -- | -- |
| 05/08/2025 | Q1 | $60.6M | $59.1M | $0.06 | -- | -- |
| 03/11/2025 | Q4 | $60M | $60.7M | $0.10 | $0.10 | -- |
| 11/07/2024 | Q3 | $57.2M | $58M | $0.10 | $0.06 | $0.04 |
| 08/08/2024 | Q2 | $53.8M | $55M | $0.04 | $0.07 | -$0.03 |
| 05/07/2024 | Q1 | $50M | $50.6M | $0.04 | $0.07 | -$0.03 |
| 03/06/2024 | Q4 | $50.5M | $50.7M | $0.08 | $0.09 | -$0.01 |
| 11/01/2023 | Q3 | -- | -- | $0.07 | $0.09 | -$0.02 |
| 08/09/2023 | Q2 | -- | -- | $0.06 | $0.04 | $0.02 |
| 05/08/2023 | Q1 | -- | -- | $0.04 | $0.05 | -$0.01 |
| 03/02/2023 | Q4 | -- | -- | $0.06 | $0.04 | $0.02 |
| 11/01/2022 | Q3 | -- | -- | $0.03 | $0.04 | -$0.01 |
| 08/02/2022 | Q2 | -- | -- | $0.02 | $0.05 | -$0.03 |
| 05/03/2022 | Q1 | -- | -- | $0.04 | $0.06 | -$0.02 |
| 03/07/2022 | Q4 | -- | -- | $0.10 | $0.06 | $0.04 |
| 11/01/2021 | Q3 | -- | -- | $0.04 | $0.04 | -$0.00 |
| 08/03/2021 | Q2 | -- | -- | $0.04 | $0.03 | $0.01 |
| 05/03/2021 | Q1 | -- | -- | $0.04 | $0.05 | -$0.01 |
| 03/03/2021 | Q4 | -- | -- | $0.12 | $0.05 | $0.07 |
| 11/04/2020 | Q3 | -- | -- | $0.07 | $0.09 | -$0.02 |
| 08/04/2020 | Q2 | -- | -- | $0.48 | $0.26 | $0.22 |
| 05/04/2020 | Q1 | -- | -- | $0.11 | $0.08 | $0.03 |
| 12/31/2019 | Q4 | -- | -- | $0.06 | $0.07 | -$0.01 |
| 09/30/2019 | Q3 | -- | -- | $0.07 | $0.07 | $0.01 |
Viemed Healthcare Earnings Questions
-
How Much did Viemed Healthcare Generate in Revenue Last Quarter?
Viemed Healthcare reported $59.1M worth of top line sales in its most recent quarter.
-
Did Viemed Healthcare Beat Earnings Last Quarter?
Viemed Healthcare announced earnings per share of $0.06 which represents a beat of analyst forecast a -- per share.
-
Is Viemed Healthcare Profitable?
Viemed Healthcare reported $33.3M that represents $0.80 per share over the last quarter.
-
What is the Analyst Consensus for Viemed Healthcare EPS Next Year?
Viemed Healthcare's earnings are forecast to grow from $0.28 per share to $0.28 per share next year representing an increase of 12%.
-
When is Viemed Healthcare's Earnings Date?
Viemed Healthcare's next earnings date is August 8, 2025.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is up 3.06% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 9.94% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 12.44% over the past day.
